Neurocrine Biosciences | Marktkapitalisierung



Market Capitalization Veränderung Datum
AbbVie USD 350.71B 19.93B 2025-05
Acadia Pharmaceuticals USD 2.85B 80M 2025-05
Agios Pharmaceuticals USD 1.72B 21M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Alnylam Pharmaceuticals USD 33.46B 1.67B 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Cytokinetics USD 3.88B 907M 2025-05
Dynavax Technologies USD 1.29B 325M 2025-05
Exelixis USD 13.18B 2.84B 2025-05
Gilead Sciences USD 128.54B 11.15B 2025-05
Halozyme Therapeutics USD 8.69B 811M 2025-05
Incyte USD 14.04B 2.32B 2025-05
Ionis Pharmaceuticals USD 4.88B 80M 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Pfizer USD 135.11B 8.61B 2025-05
Prothena USD 745M 155M 2024-12
Regeneron Pharmaceuticals USD 66.28B 3.05B 2025-05
Repligen USD 7.86B 711M 2025-05
Sarepta Therapeutics USD 4.64B 1.55B 2025-05
Teva Pharmaceutical Industries ILS 67.9B 3.88B 2025-05
Ultragenyx Pharmaceutical USD 2.9B 495M 2025-05
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



Neurocrine Biosciences Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.